Suchergebnisse - "Ding, Jian"

PubPharm (31)

1

Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations

enthalten in: Journal of medicinal chemistry | 2022

von Chen, H. | Lai, M. | Zhang, T. | +9

2

LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo

enthalten in: Cancer science | 2022

von Liu, Y. | Lai, M. | Li, S. | +20

3

The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer

enthalten in: Cancer biology & medicine | 2022

von He, T. | Gao, Y. | Fang, Y. | +5

4

BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2021

von Xia, L. | Liu, J. | Zheng, Z. | +6

CommentIn: Mol Ther. 2021 Oct 6;29(10):2896-2897. - PMID 34559988

5

Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

enthalten in: Molecular cancer | 2020

von Zhang, T. | Qu, R. | Chan, S. | +18

ErratumIn: Mol Cancer. 2021 Aug 17;20(1):102. - PMID 34404402

6

Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy

enthalten in: Current medical science | 2020

von Lin, Z. | Ding, J. | Sun, G. | +5

7

AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition

enthalten in: Acta pharmacologica Sinica | 2019

von Zhang, K. | Shen, Q. | Fang, Y. | +3

ErratumIn: Acta Pharmacol Sin. 2020 May;41(5):733-734. - PMID 32060412

8

Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Karches, C. | Benmebarek, M. | Schmidbauer, M. | +18

9

Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFRL858R/T790M/C797S)

enthalten in: Journal of medicinal chemistry | 2019

von Shen, J. | Zhang, T. | Zhu, S. | +11

10

Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation

enthalten in: Journal of medicinal chemistry | 2018

von Hao, Y. | Lyu, J. | Qu, R. | +11